Achieve Life Sciences, Inc. (QUIT)
NASDAQ: QUIT · Real-Time Price · USD
6.29
-0.16 (-2.48%)
At close: Nov 12, 2026, 4:00 PM EST
6.41
+0.12 (1.91%)
After-hours: Nov 12, 2026, 6:53 PM EST
Achieve Life Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 59.74 | 20.93 | 12.75 | 15.55 | 24.77 | 43.02 |
Short-Term Investments | 141.78 | 15.48 | 21.61 | - | - | - |
Cash & Short-Term Investments | 201.52 | 36.4 | 34.36 | 15.55 | 24.77 | 43.02 |
Cash Growth | 318.83% | 5.95% | 121.02% | -37.24% | -42.42% | 20.00% |
Other Receivables | - | - | - | 0.11 | 0.11 | 0.15 |
Receivables | - | - | - | 0.11 | 0.11 | 0.15 |
Prepaid Expenses | 1.89 | 3.49 | 2.11 | 1.33 | 2.45 | 1.42 |
Total Current Assets | 203.41 | 39.89 | 36.47 | 16.98 | 27.33 | 44.59 |
Property, Plant & Equipment | 0.97 | 0.07 | 0.13 | 0.07 | 0.12 | 0.06 |
Goodwill | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 |
Other Intangible Assets | 0.75 | 0.75 | 0.98 | 1.2 | 1.42 | 1.64 |
Other Long-Term Assets | 0.25 | 0.05 | 0.03 | 0.09 | 0.07 | 0.18 |
Total Assets | 206.42 | 41.79 | 38.63 | 19.37 | 29.97 | 47.52 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.6 | 0.87 | 1.95 | 0.62 | 1.66 | 0.84 |
Accrued Expenses | 8.64 | 2.89 | 4.68 | 2.94 | 3.81 | 3.64 |
Current Portion of Long-Term Debt | 7.45 | 3.7 | - | 16.66 | 16.07 | - |
Current Portion of Leases | 0.29 | 0.06 | 0.06 | 0.06 | 0.06 | 0.07 |
Other Current Liabilities | 1.41 | 1.56 | - | 0.53 | - | - |
Total Current Liabilities | 19.39 | 9.08 | 6.68 | 20.81 | 21.6 | 4.55 |
Long-Term Debt | 5.6 | 11.19 | 9.84 | - | - | 14.92 |
Long-Term Leases | 0.71 | 0.01 | 0.07 | 0.01 | 0.07 | 0 |
Other Long-Term Liabilities | - | - | 1.15 | - | - | - |
Total Liabilities | 25.69 | 20.27 | 17.73 | 20.82 | 21.67 | 19.47 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.18 | 0.12 | 0.1 | 0.09 | 0.09 | 0.08 |
Additional Paid-In Capital | 537.99 | 281.61 | 226.34 | 164.21 | 144.15 | 121.55 |
Retained Earnings | -357.27 | -260.23 | -205.58 | -165.75 | -135.94 | -93.59 |
Comprehensive Income & Other | -0.17 | 0.01 | 0.03 | 0 | 0 | 0 |
Shareholders' Equity | 180.73 | 21.52 | 20.9 | -1.45 | 8.3 | 28.04 |
Total Liabilities & Equity | 206.42 | 41.79 | 38.63 | 19.37 | 29.97 | 47.52 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 14.05 | 14.96 | 9.96 | 16.73 | 16.2 | 14.99 |
Net Cash (Debt) | 187.47 | 21.45 | 24.4 | -1.19 | 8.57 | 28.03 |
Net Cash Growth | 391.33% | -12.10% | - | - | -69.41% | -21.62% |
Net Cash Per Share | 2.44 | 0.49 | 0.76 | -0.06 | 0.81 | 3.45 |
Filing Date Shares Outstanding | 110.03 | 53.24 | 34.69 | 34.25 | 17.93 | 9.46 |
Total Common Shares Outstanding | 109.78 | 53.23 | 34.69 | 21.17 | 17.9 | 9.45 |
Working Capital | 184.03 | 30.81 | 29.79 | -3.83 | 5.73 | 40.04 |
Book Value Per Share | 1.65 | 0.40 | 0.60 | -0.07 | 0.46 | 2.97 |
Tangible Book Value | 178.95 | 19.73 | 18.89 | -3.68 | 5.85 | 25.37 |
Tangible Book Value Per Share | 1.63 | 0.37 | 0.54 | -0.17 | 0.33 | 2.68 |
Machinery | - | 0.14 | 0.14 | - | - | - |
Leasehold Improvements | - | 0.03 | 0.03 | - | - | - |